H.R. 3067 (112th): Accelerating the End of Breast Cancer Act of 2011

Sep 26, 2011 (112th Congress, 2011–2013)
Died (Referred to Committee)
Karen Bass
Representative for California's 33rd congressional district
Read Text »
Last Updated
Sep 26, 2011
11 pages
Related Bills
S. 3237 (Related)
Accelerating the End of Breast Cancer Act of 2012

Referred to Committee
Last Action: May 24, 2012


This bill was introduced on September 26, 2011, in a previous session of Congress, but was not enacted.

Introduced Sep 26, 2011
Referred to Committee Sep 26, 2011
Full Title

To provide for the establishment of a Commission to Accelerate the End of Breast Cancer.


No summaries available.

235 cosponsors (150D, 85R) (show)

House Energy and Commerce


The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Accelerating the End of Breast Cancer Act of 2011 - Directs the President to establish the Commission to Accelerate the End of Breast Cancer to help end breast cancer by January 1, 2020.
Directs the Commission to:
(1) identify opportunities and ideas within government and the private sector that are key components in achieving the end of breast cancer and which have been overlooked, yet are ripe for collaboration and investment;
(2) recommend projects to leverage such opportunities and ideas in the areas of the primary prevention of breast cancer and the causes and prevention of breast cancer metastasis; and
(3) ensure that its activities are coordinated with, and do not duplicate the efforts of, programs and laboratories of other government agencies.
Directs the President to enter into an agreement with the Institute of Medicine for an evaluation of the Commission's progress.
Terminates the Commission on June 1, 2020.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 3067 (112th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus